1. Home
  2. ABLV vs RGNT Comparison

ABLV vs RGNT Comparison

Compare ABLV & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABLV

Able View Global Inc.

HOLD

Current Price

$0.74

Market Cap

39.5M

Sector

N/A

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$6.56

Market Cap

35.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABLV
RGNT
Founded
2015
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
35.6M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
ABLV
RGNT
Price
$0.74
$6.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.6K
39.5K
Earning Date
09-30-2025
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$114,319,869.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$5.75
52 Week High
$1.77
$8.35

Technical Indicators

Market Signals
Indicator
ABLV
RGNT
Relative Strength Index (RSI) 56.53 45.68
Support Level $0.65 $6.12
Resistance Level $0.77 $7.46
Average True Range (ATR) 0.07 0.58
MACD 0.01 0.00
Stochastic Oscillator 64.29 25.02

Price Performance

Historical Comparison
ABLV
RGNT

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: